Video Experimental Relacionado

Updated: Sep 9, 2025

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

ECD, un nuevo receptor de andrógenos promueve la tumorigénesis del cáncer de próstata mediante la regulación de la

Mohsin Raza¹, Asher Rajkumar Rajan¹, Benjamin B Kennedy¹

¹Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE, USA.

|September 4, 2025

Resumen

Este estudio revela que la ciclina extracelular D (ECD) es un nuevo gen diana del receptor de andrógenos (AR) crucial para la progresión del cáncer de próstata (PC). La sobreexpresión de ECD promueve el crecimiento tumoral y mejora la glucólisis, destacando su papel en la tumorigénesis PC.

Área de la Ciencia:

Oncología molecular
Biología del cáncer
Endocrinología

Sus antecedentes:

La señalización del receptor de andrógenos (AR) es un factor clave en el desarrollo y la progresión del cáncer de próstata (PC).
El papel de los genes específicos de AR en el mantenimiento de la oncogénesis de PC requiere una mayor aclaración.
Se ha observado que la ciclina D extracelular (ECD) se correlaciona con la expresión de AR en PC.

Objetivo del estudio:

Investigar el papel funcional de la ciclina extracelular D (ECD) en la tumorigénesis del cáncer de próstata (PC) mediado por AR.
Determinar si la ECD es un gen diana directo del receptor de andrógenos (AR) y dilucidar su mecanismo en la progresión de la PC.

Principales métodos:

Análisis de la base de datos TCGA para la correlación entre la expresión ECD y AR.
Tratamiento con dihidrotestosterona (DHT) y eliminación de AR (KD) en líneas celulares de PC para evaluar la regulación de la ECD.
Análisis bioinformático del promotor de ECD para los elementos de respuesta a los andrógenos (AREs) y ChIP-qPCR para la ocupación de AR.
Estudios de eliminación de ECD (KO) y sobreexpresión en células PC y modelos de xenotransplante.
Secuenciación del ARN (RNA-seq) y evaluación de la expresión génica glicolítica y la absorción de glucosa.

Principales resultados:

Se observó una correlación positiva entre la expresión de ECD y AR en los datos de pacientes PC.
El tratamiento con DHT aumentó la expresión de ECD, mientras que el AR knockdown la redujo, confirmando la regulación de AR.
El promotor de ECD contiene AREs funcionales, y la AR se une al promotor de ECD cuando se estimula la DHT.
El knockout de ECD redujo los rasgos oncogénicos en las células PC, y la sobreexpresión de ECD aumentó el crecimiento tumoral y la glucólisis.
La ECD se asocia y estabiliza el ARNm de los genes glicolíticos clave, promoviendo una mayor absorción de glucosa.

Conclusiones:

La ciclina D extracelular (ECD) es un nuevo gen diana del receptor de andrógenos (AR) que juega un papel importante en la tumorigénesis del cáncer de próstata (PC).
La ECD promueve la progresión de la PC al mejorar la glucólisis y la proliferación de las células tumorales, lo que la convierte en un objetivo terapéutico potencial.
Los hallazgos establecen la ECD como un mediador crítico de la señalización de AR en la conducción de la oncogénesis PC.

Más Videos Relacionados

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Videos de Conceptos Relacionados

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

GPCRs Regulate Adenylyl Cylase Activity

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...

cAMP-dependent Protein Kinase Pathways

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...